Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Post-Effective Amendment No. 1 to Registration Statement (Form F-1) and related prospectus of Scinai Immunotherapeutics Ltd. of our report dated April 17, 2023, with respect to the financial statements of Scinai Immunotherapeutics Ltd. included in its Annual Report (Form 20-F) for the year ended December 31, 2024, filed with the Securities and Exchange Commission.
| /s/ Kost Forer Gabbay & Kasierer |
Kost Forer Gabbay & Kasierer
A member firm of Ernst & Young Global
Tel Aviv, Israel
May 12, 2025